U.S. FDA· @FDA · X·· 8 小时前精选AI 评分42
AI 导读
FDA 代理局长 Kyle Diamantas 与 @SecKennedy 在得克萨斯州奥斯汀出席活动，讨论正在改变临床试验的新举措。引用内容显示，FDA 近期启动 Operation Trialblazer 下一阶段即 Expedited IND 试点，目标是让药物开发者与美国领先研究机构对接，加快 Phase 1 IND 申报。
推荐理由
FDA 代理局长在活动中介绍临床试验新举措，并借引用披露 Expedited IND 试点，读者可了解该试点的目标与推进方式。
正文
Yesterday, Acting FDA Commissioner Kyle Diamantas joined @SecKennedy at an event in Austin, Texas to discuss new initiatives transforming clinical trials.
.@FDA_KyleD on @FDA's recent launch of the next phase of Operation Trialblazer: the Expedited IND Pilot. The goal is simple: connect drug developers with leading American research institutions to accelerate Phase 1 IND submissions and strengthen medical innovation here at home.在 X 查看被引用的帖子
来源：U.S. FDA · x.com